BIOEMTECH is internationally recognized for its innovative preclinical imaging technologies, including the β-eye, γ-eye and φ-eye systems, designed to accelerate radiopharmaceutical and molecular imaging research.
This site is available in the United Kingdom, would you like to view the United Kingdom version?
